← Leaderboards
Jennifer Gewandter
University Of Rochester
$4,802,560
Attributed
$11,094,802
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.1M · FY2019–25$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,594,802 · 5
FDA$500,000 · 1
By mechanism
UH3$7,081,684 · 1
UG3$1,600,475 · 1
U24$1,243,830 · 1
U01$500,000 · 1
R21$362,989 · 1
K24$305,824 · 1
Top collaborators
- Robert R Edwards3 shared
- Roy Freeman2 shared
- Robert H Dworkin1 shared
- John Douglas Markman1 shared
- Michael P Mcdermott1 shared
- Bryce B Reeve1 shared
- Dennis C. Turk1 shared
- Denham S Ward1 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Paul Geha$5,714,678
- Sarah L. Kerns$1,745,658
- James L McGrath$7,223,694
- David C Linehan$5,269,651
- Anton P Porsteinsson$8,737,681
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical TrialsAnalgesicsDesignPainSiteParticipantPhenotypeMonitorDrug DevelopmentMeetingsLinkTrainingFoundationsRecruitDevicesChronic Low Back PainAgreementChronic PainEffective TherapyOutcome MeasureBiological MarkersCollaborationsBaseLaboratories
Grant awards (11)
Sensory Phenotyping to Enhance Neuropathic Pain Drug Development$7,081,684
UH3 · FY2025 · NS
University of Rochester Hub and Spokes for the EPPIC Network - Specialized Clinical Center$110,001
U24 · FY2024 · NS · contact PI
Sensory Phenotyping to Enhance Neuropathic Pain Drug Development$1,600,475
UG3 · FY2023 · NS
U of R Hub and Spokes for the EPPIC Network - Specialized Clinical Center$90,564
U24 · FY2023 · NS · contact PI
Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Public-Private Partnership$500,000
U01 · FY2021 · FD
Promoting high-quality pain treatment trials through mentorship of junior investigators: A focus on study conduct and method development$305,824
K24 · FY2021 · NS · contact PI
University of Rochester Hub and Spokes for the EPPIC Network - Specialized Clinical Center$151,129
U24 · FY2021 · NS
Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial$171,297
R21 · FY2020 · CA · contact PI
Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial$81,718
R21 · FY2020 · CA · contact PI
University of Rochester Hub and Spokes for the EPPIC Network - Specialized Clinical Center$892,136
U24 · FY2019 · NS · contact PI
Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial$109,974
R21 · FY2019 · CA · contact PI